HK1079688A1 - Statin product for enhancing cognitive maintenance - Google Patents

Statin product for enhancing cognitive maintenance

Info

Publication number
HK1079688A1
HK1079688A1 HK05111808.4A HK05111808A HK1079688A1 HK 1079688 A1 HK1079688 A1 HK 1079688A1 HK 05111808 A HK05111808 A HK 05111808A HK 1079688 A1 HK1079688 A1 HK 1079688A1
Authority
HK
Hong Kong
Prior art keywords
statin
enhancing cognitive
galantamine
active ingredient
maintenance
Prior art date
Application number
HK05111808.4A
Other languages
English (en)
Inventor
Sean Lilienfeld
M. Gutterman Elane
Royston John Slaspool
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1079688A1 publication Critical patent/HK1079688A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
HK05111808.4A 2002-04-02 2005-12-21 Statin product for enhancing cognitive maintenance HK1079688A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36928502P 2002-04-02 2002-04-02
PCT/EP2003/003324 WO2003082298A1 (en) 2002-04-02 2003-03-28 Statin therapy for enhancing cognitive maintenance

Publications (1)

Publication Number Publication Date
HK1079688A1 true HK1079688A1 (en) 2006-04-13

Family

ID=28675573

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111808.4A HK1079688A1 (en) 2002-04-02 2005-12-21 Statin product for enhancing cognitive maintenance

Country Status (22)

Country Link
EP (1) EP1492539B1 (xx)
JP (1) JP2005525391A (xx)
KR (1) KR100986194B1 (xx)
CN (1) CN100528164C (xx)
AT (1) ATE331523T1 (xx)
AU (1) AU2003226753B2 (xx)
BR (1) BR0308293A (xx)
CA (1) CA2480275C (xx)
CY (1) CY1105545T1 (xx)
DE (1) DE60306503T2 (xx)
DK (1) DK1492539T3 (xx)
EA (1) EA013069B1 (xx)
ES (1) ES2268393T3 (xx)
HK (1) HK1079688A1 (xx)
IL (2) IL164317A0 (xx)
MX (1) MXPA04009535A (xx)
NO (1) NO20044698L (xx)
NZ (1) NZ536111A (xx)
PL (1) PL211160B1 (xx)
PT (1) PT1492539E (xx)
UA (1) UA79605C2 (xx)
WO (1) WO2003082298A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
AU2005232447A1 (en) * 2004-04-14 2005-10-27 Warner-Lambert Company Llc Therapeutic combination for treatment of Alzheimers disease
WO2005123068A2 (en) * 2004-06-08 2005-12-29 Axonyx, Inc. Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor
GB0607946D0 (en) * 2006-04-21 2006-05-31 Minster Res The Ltd Mono and combination therapy
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
TWI432195B (zh) 2007-10-03 2014-04-01 Kowa Co 神經細胞死亡抑制劑
US20160303146A1 (en) * 2013-12-13 2016-10-20 David A. TABACZYNSKI Inhibition of isoprenoid biosynthetic pathways to treat neuroinflammatory disorders

Also Published As

Publication number Publication date
NZ536111A (en) 2006-03-31
CA2480275C (en) 2011-08-16
CY1105545T1 (el) 2010-07-28
WO2003082298A1 (en) 2003-10-09
EP1492539B1 (en) 2006-06-28
JP2005525391A (ja) 2005-08-25
DE60306503T2 (de) 2007-06-21
MXPA04009535A (es) 2005-01-25
AU2003226753B2 (en) 2007-06-28
PT1492539E (pt) 2006-11-30
PL371551A1 (en) 2005-06-27
KR100986194B1 (ko) 2010-10-07
CN100528164C (zh) 2009-08-19
IL164317A (en) 2010-04-29
EA013069B1 (ru) 2010-02-26
CN1642555A (zh) 2005-07-20
EA200401295A1 (ru) 2005-02-24
KR20040096608A (ko) 2004-11-16
AU2003226753A1 (en) 2003-10-13
CA2480275A1 (en) 2003-10-09
ES2268393T3 (es) 2007-03-16
DK1492539T3 (da) 2006-10-30
ATE331523T1 (de) 2006-07-15
DE60306503D1 (de) 2006-08-10
IL164317A0 (en) 2005-12-18
NO20044698L (no) 2004-10-29
BR0308293A (pt) 2004-12-28
EP1492539A1 (en) 2005-01-05
UA79605C2 (en) 2007-07-10
PL211160B1 (pl) 2012-04-30

Similar Documents

Publication Publication Date Title
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
DE69502939D1 (de) Sublinguales oder bukkales arzneimittel
MXPA02011303A (es) Nueva composicion farmaceutica.
CA2427227A1 (en) Lactam compound
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
PL309604A1 (en) Pharmaceutical composition for treating nicotin dependence
MX9706647A (es) Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina.
ATE273693T1 (de) Proteinhaltige arzneimittel
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
CA2429793A1 (en) Interferon therapeutic effect enhancer
WO2004030684A3 (en) Kavalactone product
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
GR3032531T3 (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150328